{
"NDC": [
{
"NDCCode": "70163-0047-2",
"PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (70163-0047-2) / 120 TABLET in 1 BOTTLE, PLASTIC (70163-0047-1) ",
"NDC11Code": "70163-0047-02",
"ProductNDC": "70163-0047",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Anxiety Relief",
"NonProprietaryName": "Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Aurum Metallicum, Gelsemium Sempervirens, Hyoscyamus Niger, Ignatia Amara, Kali Carbonicum, Moschus, Natrum Muriaticum, Piper Methysticum",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20260415",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "ACONITUM NAPELLUS WHOLE; SILVER NITRATE; ARSENIC TRIOXIDE; GOLD; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; STRYCHNOS IGNATII SEED; POTASSIUM CARBONATE; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; SODIUM CHLORIDE; PIPER METHYSTICUM ROOT",
"StrengthNumber": "9; 8; 9; 8; 8; 6; 6; 12; 12; 6; 7",
"StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
"Pharm_Classes": "Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",
"Status": "Active",
"LastUpdate": "2026-04-16",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260415",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve ■ occasional minor anxiety ■ fear ■ anguish ■ stress and worry of everyday life ■ nervousness*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0010-2",
"PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (70163-0010-2) / 125 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (70163-0010-1) ",
"NDC11Code": "70163-0010-02",
"ProductNDC": "70163-0010",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "No More Monsters",
"NonProprietaryName": "Calcarea Carbonica, Kali Phosphoricum, Lycopodium Clavatum, Passiflora Incarnata, Gallicum Acidum",
"DosageFormName": "TABLET, CHEWABLE",
"RouteName": "ORAL",
"StartMarketingDate": "20260310",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "OYSTER SHELL CALCIUM CARBONATE, CRUDE; DIBASIC POTASSIUM PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; PASSIFLORA INCARNATA FLOWERING TOP; GALLIC ACID MONOHYDRATE",
"StrengthNumber": "6; 6; 6; 4; 6",
"StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
"Status": "Active",
"LastUpdate": "2026-03-11",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260310",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve ■ frightful dreams ■ sleeplessness ■ frequent waking*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0012-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0012-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0012-1) ",
"NDC11Code": "70163-0012-02",
"ProductNDC": "70163-0012",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Nervefix Sciatica",
"NonProprietaryName": "Belladonna, Cimicifuga Racemosa, Gelsemium Sempervirens, Spigelia Anthelmia, Gnaphalium Polycephalum, Magnesia Phosphorica",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260203",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "ATROPA BELLADONNA; BLACK COHOSH; GELSEMIUM SEMPERVIRENS ROOT; SPIGELIA ANTHELMIA WHOLE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE",
"StrengthNumber": "6; 6; 6; 6; 6; 12",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
"Status": "Active",
"LastUpdate": "2026-09-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260203",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve. ■ sciatica pain ■ pain extending into legs ■ neuralgia ■ back pain. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone."
},
{
"NDCCode": "70163-0013-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0013-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0013-1) ",
"NDC11Code": "70163-0013-02",
"ProductNDC": "70163-0013",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Animal Hair And Dander",
"NonProprietaryName": "Adrenalinum, Allium Cepa, Arsenicum Iodatum, Cat (dander), Dog (dander), Euphrasia Officinalis, Histaminum Hydrochloricum, Sabadilla, Sheep Wool, Silicea",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260410",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "EPINEPHRINE; ONION; ARSENIC TRIIODIDE; FELIS CATUS DANDER; CANIS LUPUS FAMILIARIS DANDER; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; SCHOENOCAULON OFFICINALE SEED; SHEEP WOOL; SILICON DIOXIDE",
"StrengthNumber": "6; 6; 6; 12; 12; 6; 12; 6; 12; 12",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-04-14",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260410",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve allergy symptoms. ■ congestion ■itchy, watery eyes ■ sneezing ■ rashes*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0017-2",
"PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (70163-0017-2) / 125 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (70163-0017-1) ",
"NDC11Code": "70163-0017-02",
"ProductNDC": "70163-0017",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Peace And Quiet",
"NonProprietaryName": "Chamomilla, Ignatia Amara, Lycopodium Clavatum, Magnesium Muriatica, Passiflora Incarnata",
"DosageFormName": "TABLET, CHEWABLE",
"RouteName": "ORAL",
"StartMarketingDate": "20260302",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "MATRICARIA CHAMOMILLA WHOLE; STRYCHNOS IGNATII SEED; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; PASSIFLORA INCARNATA FLOWERING TOP",
"StrengthNumber": "4; 6; 6; 6; 4",
"StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
"Pharm_Classes": "Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
"Status": "Active",
"LastUpdate": "2026-03-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260302",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve ■ fussiness ■ oversensitivity ■ sleeplessness*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0018-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (70163-0018-2) / 30 mL in 1 BOTTLE, SPRAY (70163-0018-1) ",
"NDC11Code": "70163-0018-02",
"ProductNDC": "70163-0018",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Thyroid Support",
"NonProprietaryName": "Calcarea Carbonica, Calcarea Iodata, Causticum, Ferrum Iodatum, Fucus Vesiculosus, Kali Iodatum, Natrum Muriaticum, Thyroidinum (bovine)",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20260304",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "OYSTER SHELL CALCIUM CARBONATE, CRUDE; CALCIUM IODIDE; CAUSTICUM; FERROUS IODIDE; FUCUS VESICULOSUS; POTASSIUM IODIDE; SODIUM CHLORIDE; THYROID, BOVINE",
"StrengthNumber": "10; 6; 10; 10; 6; 6; 10; 6",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",
"Status": "Active",
"LastUpdate": "2026-09-09",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260304",
"SamplePackage": "N",
"IndicationAndUsage": "May help to provide temporary glandular support for symptoms of. ■ low energy ■ low metabolism ■ cold hands & feet ■ melancholy*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone."
},
{
"NDCCode": "70163-0019-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0019-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0019-1) ",
"NDC11Code": "70163-0019-02",
"ProductNDC": "70163-0019",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Mold, Yeast And Dust",
"NonProprietaryName": "Adrenalinum, Arsenicum Iodatum, Aspergillus Flavus, Aspergillus Fumigatus, Aspergillus Glaucus, Aspergillus Nidulans, Aspergillus Niger, Candida Albicans, Dermatophagoides Farinae, Histaminum Hydrochloricum, Lycopodium Clavatum, Mucor Plumbeus, Natrum Sulphuricum, Penicillium Digitatum, Penicillium Roquefortii, Saccharomyces Cerevisiae, Silicea",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260202",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "EPINEPHRINE; ARSENIC TRIIODIDE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; EUROTIUM HERBARIORUM; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; DERMATOPHAGOIDES FARINAE; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; MUCOR PLUMBEUS; SODIUM SULFATE; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI; SACCHAROMYCES CEREVISIAE; SILICON DIOXIDE",
"StrengthNumber": "6; 6; 12; 12; 12; 12; 12; 12; 12; 12; 6; 12; 6; 12; 12; 12; 12",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-02-10",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260202",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve allergy symptoms. ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0020-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (70163-0020-2) / 24 mL in 1 BOTTLE, SPRAY (70163-0020-1) ",
"NDC11Code": "70163-0020-02",
"ProductNDC": "70163-0020",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Allergy Nasal",
"NonProprietaryName": "Adrenalinum, Allium Cepa, Ambrosia Artemisiaefolia, Echinacea (angustifolia), Gelsemium Sempervirens, Kali Iodatum, Sanguinaria Canadensis, Sticta Pulmonaria",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20260514",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "EPINEPHRINE; ONION; AMBROSIA ARTEMISIIFOLIA WHOLE; ECHINACEA ANGUSTIFOLIA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; POTASSIUM IODIDE; SANGUINARIA CANADENSIS ROOT; LOBARIA PULMONARIA",
"StrengthNumber": "6; 6; 12; 6; 6; 9; 6; 6",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-05-15",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260514",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve allergy symptoms. ■ sinus pressure ■ sinus headache ■ congestion ■ runny nose ■ dry nasal passages ■ sneezing *. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0023-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0023-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0023-1) ",
"NDC11Code": "70163-0023-02",
"ProductNDC": "70163-0023",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Grass Pollen",
"NonProprietaryName": "Adrenalinum, Allium Cepa, Arsenicum Iodatum, Oats (avena Sativa), Brome Grass (bromus Inermis), Bermuda Grass (cynodon Dactylon), Orchard Grass (dactylis Glomerata), Euphrasia Officinalis, Meadow Grass (festuca Elatior Pratensis), Histaminum Hydrochloricum, Perennial Rye Grass (lolium Perenne), Timothy Grass (phleum Pratense), Sabadilla, Sanguinaria Canadensis, Rye Grass (secale Cereale), Johnson Grass (sorghum Halepense), Wheat Grass (triticum Aestivum), Corn (zea Mays)",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260310",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "EPINEPHRINE; ONION; ARSENIC TRIIODIDE; AVENA SATIVA POLLEN; BROMUS INERMIS POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; EUPHRASIA STRICTA; LOLIUM PRATENSE POLLEN; HISTAMINE DIHYDROCHLORIDE; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; SCHOENOCAULON OFFICINALE SEED; SANGUINARIA CANADENSIS ROOT; SECALE CEREALE POLLEN; SORGHUM HALEPENSE POLLEN; TRITICUM AESTIVUM POLLEN; ZEA MAYS POLLEN",
"StrengthNumber": "6; 6; 6; 12; 12; 12; 12; 6; 12; 12; 12; 12; 6; 6; 12; 12; 12; 12",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-03-11",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260310",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve allergy symptoms. ■ runny nose ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0024-2",
"PackageDescription": "1 BOTTLE, GLASS in 1 CARTON (70163-0024-2) / 120 mL in 1 BOTTLE, GLASS (70163-0024-1) ",
"NDC11Code": "70163-0024-02",
"ProductNDC": "70163-0024",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Cough And Mucus Night",
"NonProprietaryName": "Antimonium Tartaricum, Avena Sativa, Bryonia (alba), Chamomilla, Drosera (rotundifolia), Hepar Sulphuris Calcareum, Hydrastis Canadensis, Kali Bichromicum, Passiflora Incarnata, Pulsatilla (pratensis), Sambucus Nigra, Stannum Metallicum, Sulphur",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260202",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "ANTIMONY POTASSIUM TARTRATE; AVENA SATIVA FLOWERING TOP; BRYONIA ALBA ROOT; MATRICARIA CHAMOMILLA WHOLE; DROSERA ROTUNDIFOLIA WHOLE; CALCIUM SULFIDE; GOLDENSEAL; POTASSIUM DICHROMATE; PASSIFLORA INCARNATA FLOWERING TOP; PULSATILLA PRATENSIS WHOLE; SAMBUCUS NIGRA FLOWERING TOP; TIN; SULFUR",
"StrengthNumber": "6; 8; 6; 8; 6; 12; 5; 12; 6; 6; 3; 12; 12",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Active",
"LastUpdate": "2026-02-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260202",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve ■ chest congestion ■ hacking cough ■ thick mucus in chest, throat and nose*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0025-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0025-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0025-1) ",
"NDC11Code": "70163-0025-02",
"ProductNDC": "70163-0025",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Candida Yeast Care",
"NonProprietaryName": "Baptisia Tinctoria, Bryonia (alba), Candida Albicans, Candida Parapsilosis, Echinacea (angustifolia), Eupatorium Perfoliatum, Thuja Occidentalis, Viscum Album",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260501",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "BAPTISIA TINCTORIA WHOLE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP",
"StrengthNumber": "3; 3; 12; 12; 3; 6; 3; 3",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",
"Status": "Active",
"LastUpdate": "2026-05-05",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260501",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve. ■ symptoms of yeast infection ■ itching ■ burning ■ discharge ■ odor*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0029-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0029-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0029-1) ",
"NDC11Code": "70163-0029-02",
"ProductNDC": "70163-0029",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Tree Pollen",
"NonProprietaryName": "Acer Negundo, Acer Rubrum, Adrenalinum, Allium Cepa, Arsenicum Iodatum, Betula Nigra, Euphrasia Officinalis, Fraxinus Americana, Histaminum Hydrochloricum, Ligustrum Vulgare, Liquidambar Styraciflua, Morus Alba, Pinus Strobus, Populus Deltoides, Quercus Rubra, Sabadilla, Salix Nigra, Sanguinaria Canadensis",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260304",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; EPINEPHRINE; ONION; ARSENIC TRIIODIDE; BETULA NIGRA POLLEN; EUPHRASIA STRICTA; FRAXINUS AMERICANA POLLEN; HISTAMINE DIHYDROCHLORIDE; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; MORUS ALBA POLLEN; PINUS STROBUS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SCHOENOCAULON OFFICINALE SEED; SALIX NIGRA POLLEN; SANGUINARIA CANADENSIS ROOT",
"StrengthNumber": "12; 12; 6; 6; 6; 12; 6; 12; 12; 12; 12; 12; 12; 12; 12; 6; 12; 6",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-09-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260304",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve allergy symptoms. ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone."
},
{
"NDCCode": "70163-0030-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0030-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0030-1) ",
"NDC11Code": "70163-0030-02",
"ProductNDC": "70163-0030",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Sinufix",
"NonProprietaryName": "Thuja Occidentalis, Antimonium Tartaricum, Kali Bichromicum, Mercurius Iodatus Ruber, Spongia Tosta, Hepar Sulphuris Calcareum",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260422",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "THUJA OCCIDENTALIS LEAFY TWIG; ANTIMONY POTASSIUM TARTRATE; POTASSIUM DICHROMATE; MERCURIC IODIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; CALCIUM SULFIDE",
"StrengthNumber": "6; 6; 6; 12; 10; 10",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Active",
"LastUpdate": "2026-04-25",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260422",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve. ■ sinus symptoms ■ sinus headache ■ nasal congestion ■ sinus pressure ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0031-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0031-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0031-1) ",
"NDC11Code": "70163-0031-02",
"ProductNDC": "70163-0031",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Pollen Hayfever",
"NonProprietaryName": "Adrenalinum, Allium Cepa, Ambrosia Artemisiaefolia, Arsenicum Iodatum, Mugwort Pollen (artemisia Vulgaris), Bellis Perennis, Brassica Spp, Chenopodium Album, Euphrasia Officinalis, Histaminum Hydrochloricum, Alfalfa Pollen (medicago Sativa), Phleum Pratense, Yellow Dock Pollen (rumex Crispus), Sabadilla, Silicea, Goldenrod Pollen (solidago Canadensis), Dandelion Pollen (taraxacum Officinale), Red Clover Pollen (trifolium Pratense), Xanthium Strumarium",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260505",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "EPINEPHRINE; ONION; AMBROSIA ARTEMISIIFOLIA WHOLE; ARSENIC TRIIODIDE; ARTEMISIA VULGARIS POLLEN; BELLIS PERENNIS WHOLE; BRASSICA RAPA SUBSP. OLEIFERA POLLEN; CHENOPODIUM ALBUM POLLEN; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; MEDICAGO SATIVA POLLEN; PHLEUM PRATENSE POLLEN; RUMEX CRISPUS POLLEN; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SOLIDAGO CANADENSIS POLLEN; TARAXACUM OFFICINALE POLLEN; TRIFOLIUM PRATENSE POLLEN; XANTHIUM STRUMARIUM POLLEN",
"StrengthNumber": "6; 6; 12; 6; 12; 12; 12; 12; 6; 12; 12; 12; 12; 6; 12; 12; 12; 12; 12",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-05-07",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260505",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve allergy symptoms. ■ runny nose ■ congestion ■ headache ■ itchy, watery eyes, ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0033-2",
"PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (70163-0033-2) / 125 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (70163-0033-1) ",
"NDC11Code": "70163-0033-02",
"ProductNDC": "70163-0033",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "A Plus Attention",
"NonProprietaryName": "Baryta Carbonica, Calcarea Phosphorica, Silicea, Gelsemium Sempervirens, Nux Vomica, Sinapis Nigra",
"DosageFormName": "TABLET, CHEWABLE",
"RouteName": "ORAL",
"StartMarketingDate": "20260324",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "BARIUM CARBONATE; TRIBASIC CALCIUM PHOSPHATE; SILICON DIOXIDE; GELSEMIUM SEMPERVIRENS ROOT; STRYCHNOS NUX-VOMICA SEED; BLACK MUSTARD SEED",
"StrengthNumber": "10; 10; 10; 12; 12; 12",
"StrengthUnit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
"Pharm_Classes": "Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]",
"Status": "Active",
"LastUpdate": "2026-03-27",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260324",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve ■ poor concentration ■ overactive mind ■ restlessness*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0034-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0034-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0034-1) ",
"NDC11Code": "70163-0034-02",
"ProductNDC": "70163-0034",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Adrenal Support",
"NonProprietaryName": "Adrenalinum, Argentum Nitricum, Berberis Vulgaris, Natrum Muriaticum, Oleum Morrhuae, Petroleum, Vanadium",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260324",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "EPINEPHRINE; SILVER NITRATE; BERBERIS VULGARIS ROOT BARK; SODIUM CHLORIDE; COD LIVER OIL; KEROSENE; VANADIUM",
"StrengthNumber": "6; 10; 6; 10; 12; 12; 10",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-09-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260324",
"SamplePackage": "N",
"IndicationAndUsage": "May help to provide temporary glandular support for symptoms of. ■ low energy ■ low metabolism ■ inflammation ■ stress. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone."
},
{
"NDCCode": "70163-0035-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0035-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0035-1) ",
"NDC11Code": "70163-0035-02",
"ProductNDC": "70163-0035",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Allergy Care",
"NonProprietaryName": "Adrenalinum, Ragweed, Pollen (ambrosia Artemisiaefolia), Apis Mellifica, Echinacea (angustifolia), Histaminum Hydrochloricum, Ledum Palustre, Lycopodium Clavatum, Natrum Muriaticum, Sulphur",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260323",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "EPINEPHRINE; AMBROSIA ARTEMISIIFOLIA POLLEN; APIS MELLIFERA; ECHINACEA ANGUSTIFOLIA WHOLE; HISTAMINE DIHYDROCHLORIDE; RHODODENDRON TOMENTOSUM LEAFY TWIG; LYCOPODIUM CLAVATUM SPORE; SODIUM CHLORIDE; SULFUR",
"StrengthNumber": "6; 6; 6; 4; 12; 8; 6; 8; 6",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Standardized Insect Venom Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
"Status": "Active",
"LastUpdate": "2026-08-28",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260323",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve allergy symptoms of ■ nasal and sinus congestion ■ runny nose ■ skin irritations ■ sneezing ■ watery eyes*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone."
},
{
"NDCCode": "70163-0036-2",
"PackageDescription": "1 BOTTLE, GLASS in 1 CARTON (70163-0036-2) / 120 mL in 1 BOTTLE, GLASS (70163-0036-1) ",
"NDC11Code": "70163-0036-02",
"ProductNDC": "70163-0036",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Cough And Mucus",
"NonProprietaryName": "Antimonium Tartaricum, Euphrasia Officinalis, Hepar Sulphuris Calcareum, Hydrastis Canadensis, Kali Bichromicum, Pulsatilla (pratensis), Stannum Metallicum, Sulphur",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260323",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "ANTIMONY POTASSIUM TARTRATE; EUPHRASIA STRICTA; CALCIUM SULFIDE; GOLDENSEAL; POTASSIUM DICHROMATE; PULSATILLA PRATENSIS WHOLE; TIN; SULFUR",
"StrengthNumber": "6; 6; 12; 5; 12; 6; 12; 12",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Active",
"LastUpdate": "2026-03-27",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260323",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve ■ chest congestion ■ hacking cough ■ thick mucus in chest, throat and nose*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0039-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0039-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0039-1) ",
"NDC11Code": "70163-0039-02",
"ProductNDC": "70163-0039",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Uti Care",
"NonProprietaryName": "Barosma (betulina), Dulcamara, Equisetum Hyemale, Terebinthina, Sarsaparilla (smilax Regelii) Triticum Repens",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260320",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "AGATHOSMA BETULINA LEAF; SOLANUM DULCAMARA TOP; EQUISETUM HYEMALE WHOLE; TURPENTINE OIL; SMILAX ORNATA ROOT; ELYMUS REPENS ROOT",
"StrengthNumber": "5; 3; 6; 4; 4; 4",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Active",
"LastUpdate": "2026-03-23",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260320",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve. ■ bladder symptoms ■ urge to urinate ■ frequent urination ■ painful urination. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "70163-0040-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (70163-0040-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0040-1) ",
"NDC11Code": "70163-0040-02",
"ProductNDC": "70163-0040",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Cold And Flu Relief",
"NonProprietaryName": "Aconitum Napellus, Allium Cepa, Echinacea (angustifolia), Euphrasia Officinalis, Gelsemium Sempervirens, Sanguinaria Canadensis, Sticta Pulmonaria",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20260323",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "NaturalCare",
"SubstanceName": "ACONITUM NAPELLUS WHOLE; ONION; ECHINACEA ANGUSTIFOLIA WHOLE; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; SANGUINARIA CANADENSIS ROOT; LOBARIA PULMONARIA",
"StrengthNumber": "3; 6; 3; 6; 6; 6; 6",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Pharm_Classes": "Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",
"Status": "Active",
"LastUpdate": "2026-08-28",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260323",
"SamplePackage": "N",
"IndicationAndUsage": "May help temporarily relieve. ■ congestion ■ cough ■ nausea ■ sneezing ■ runny nose ■ headache ■ body ache*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone."
},
{
"NDCCode": "0009-0047-04",
"PackageDescription": "25 VIAL in 1 CARTON (0009-0047-04) / 2 mL in 1 VIAL (0009-0047-03) ",
"NDC11Code": "00009-0047-04",
"ProductNDC": "0009-0047",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Solu-medrol",
"NonProprietaryName": "Methylprednisolone Sodium Succinate",
"DosageFormName": "INJECTION, POWDER, FOR SOLUTION",
"RouteName": "INTRAMUSCULAR; INTRAVENOUS",
"StartMarketingDate": "19590402",
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA011856",
"LabelerName": "Pharmacia & Upjohn Company LLC",
"SubstanceName": "METHYLPREDNISOLONE SODIUM SUCCINATE",
"StrengthNumber": "125",
"StrengthUnit": "mg/2mL",
"Pharm_Classes": "Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",
"Status": "Active",
"LastUpdate": "2026-06-27",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "19590402",
"SamplePackage": "N",
"IndicationAndUsage": "When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-MEDROL Sterile Powder is indicated as follows. Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis. Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia. Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.",
"Description": "SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. The chemical name for methylprednisolone sodium succinate is pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-monosodium salt, (6α, 11β), and the molecular weight is 496.53. The structural formula is represented below. Methylprednisolone sodium succinate is soluble in water; it may be administered in a small volume of diluent and is well suited for intravenous use in situations where high blood levels of methylprednisolone are required rapidly. SOLU-MEDROL is available in preservative and preservative-free formulations. When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8."
},
{
"NDCCode": "0009-0047-22",
"PackageDescription": "25 VIAL in 1 CARTON (0009-0047-22) / 2 mL in 1 VIAL (0009-0047-25) ",
"NDC11Code": "00009-0047-22",
"ProductNDC": "0009-0047",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Solu-medrol",
"NonProprietaryName": "Methylprednisolone Sodium Succinate",
"DosageFormName": "INJECTION, POWDER, FOR SOLUTION",
"RouteName": "INTRAMUSCULAR; INTRAVENOUS",
"StartMarketingDate": "19590402",
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA011856",
"LabelerName": "Pharmacia & Upjohn Company LLC",
"SubstanceName": "METHYLPREDNISOLONE SODIUM SUCCINATE",
"StrengthNumber": "125",
"StrengthUnit": "mg/2mL",
"Pharm_Classes": "Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",
"Status": "Active",
"LastUpdate": "2025-12-17",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "19590402",
"SamplePackage": "N",
"IndicationAndUsage": "When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-MEDROL Sterile Powder is indicated as follows. Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis. Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia. Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.",
"Description": "SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. The chemical name for methylprednisolone sodium succinate is pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-monosodium salt, (6α, 11β), and the molecular weight is 496.53. The structural formula is represented below. Methylprednisolone sodium succinate is soluble in water; it may be administered in a small volume of diluent and is well suited for intravenous use in situations where high blood levels of methylprednisolone are required rapidly. SOLU-MEDROL is available in preservative and preservative-free formulations. When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8."
},
{
"NDCCode": "0009-0047-26",
"PackageDescription": "25 VIAL in 1 CARTON (0009-0047-26) / 2 mL in 1 VIAL (0009-0047-27) ",
"NDC11Code": "00009-0047-26",
"ProductNDC": "0009-0047",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Solu-medrol",
"NonProprietaryName": "Methylprednisolone Sodium Succinate",
"DosageFormName": "INJECTION, POWDER, FOR SOLUTION",
"RouteName": "INTRAMUSCULAR; INTRAVENOUS",
"StartMarketingDate": "19590402",
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA011856",
"LabelerName": "Pharmacia & Upjohn Company LLC",
"SubstanceName": "METHYLPREDNISOLONE SODIUM SUCCINATE",
"StrengthNumber": "125",
"StrengthUnit": "mg/2mL",
"Pharm_Classes": "Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",
"Status": "Active",
"LastUpdate": "2025-12-17",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "19590402",
"SamplePackage": "N",
"IndicationAndUsage": "When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-MEDROL Sterile Powder is indicated as follows. Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis. Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia. Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.",
"Description": "SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. The chemical name for methylprednisolone sodium succinate is pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-monosodium salt, (6α, 11β), and the molecular weight is 496.53. The structural formula is represented below. Methylprednisolone sodium succinate is soluble in water; it may be administered in a small volume of diluent and is well suited for intravenous use in situations where high blood levels of methylprednisolone are required rapidly. SOLU-MEDROL is available in preservative and preservative-free formulations. When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8."
},
{
"NDCCode": "0280-0047-36",
"PackageDescription": "18 POUCH in 1 CARTON (0280-0047-36) / 2 TABLET, EFFERVESCENT in 1 POUCH",
"NDC11Code": "00280-0047-36",
"ProductNDC": "0280-0047",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Alka-seltzer Heartburn",
"NonProprietaryName": "Anhydrous Citric Acid, Sodium Bicarbonate (heat-treated)",
"DosageFormName": "TABLET, EFFERVESCENT",
"RouteName": "ORAL",
"StartMarketingDate": "20100302",
"MarketingCategoryName": "OTC MONOGRAPH DRUG",
"ApplicationNumber": "M001",
"LabelerName": "Bayer HealthCare LLC.",
"SubstanceName": "CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE",
"StrengthNumber": "1000; 1940",
"StrengthUnit": "mg/1; mg/1",
"Pharm_Classes": "Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]",
"Status": "Active",
"LastUpdate": "2025-12-06",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20100302",
"SamplePackage": "N",
"IndicationAndUsage": "for the relief of: 1 heartburn, 2 acid indigestion, 3 upset stomach associated with these symptoms ."
},
{
"NDCCode": "0338-0047-29",
"PackageDescription": "2 BAG in 1 CARTON (0338-0047-29) / 5000 mL in 1 BAG",
"NDC11Code": "00338-0047-29",
"ProductNDC": "0338-0047",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Sodium Chloride",
"NonProprietaryName": "Sodium Chloride",
"DosageFormName": "IRRIGANT",
"RouteName": "IRRIGATION",
"StartMarketingDate": "19800530",
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA017867",
"LabelerName": "Baxter Healthcare Corporation",
"SubstanceName": "SODIUM CHLORIDE",
"StrengthNumber": "900",
"StrengthUnit": "mg/100mL",
"Pharm_Classes": "Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]",
"Status": "Active",
"LastUpdate": "2026-03-19",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "19800530",
"SamplePackage": "N",
"IndicationAndUsage": "0.9% Sodium Chloride Irrigation, USP is indicated for use as an arthroscopic irrigating fluid with endoscopic instruments during arthroscopic procedures requiring distension and irrigation of the knee, shoulder, elbow, or other bone joints.",
"Description": "0.9% Sodium Chloride Irrigation, USP is a sterile nonpyrogenic, isotonic solution in a single dose ARTHROMATIC plastic container for use as an arthroscopic irrigating solution. Each liter contains 9 g Sodium Chloride, USP (NaCl) in Water for Injection. pH 5.5 (4.5 to 7.0). Milliequivalents per liter: Sodium - 154, Chloride - 154. Osmolarity 308 mOsmol/L (calc.). No antimicrobial agent has been added. The ARTHROMATIC plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexylphthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies."
},
{
"NDCCode": "11822-0047-2",
"PackageDescription": "24 BLISTER PACK in 1 CARTON (11822-0047-2) > 1 TABLET in 1 BLISTER PACK",
"NDC11Code": "11822-0047-02",
"ProductNDC": "11822-0047",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Acid Reducer",
"NonProprietaryName": "Ranitidine",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20081203",
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA078653",
"LabelerName": "Rite Aid Corporation",
"SubstanceName": "RANITIDINE HYDROCHLORIDE",
"StrengthNumber": "150",
"StrengthUnit": "mg/1",
"Status": "Deprecated",
"LastUpdate": "2017-11-15"
},
{
"NDCCode": "15631-0047-2",
"PackageDescription": "400 PELLET in 1 PACKAGE (15631-0047-2) ",
"NDC11Code": "15631-0047-02",
"ProductNDC": "15631-0047",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Argentum Phosphoricum",
"NonProprietaryName": "Argentum Phosphoricum",
"DosageFormName": "PELLET",
"RouteName": "ORAL",
"StartMarketingDate": "20150907",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Rxhomeo Private Limited d.b.a. Rxhomeo, Inc",
"SubstanceName": "SILVER PHOSPHATE",
"StrengthNumber": "3",
"StrengthUnit": "[hp_X]/1",
"Status": "Deprecated",
"LastUpdate": "2022-01-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20211231",
"StartMarketingDatePackage": "20180101",
"SamplePackage": "N",
"IndicationAndUsage": "Condition listed above or as directed by the physician."
},
{
"NDCCode": "37662-0047-2",
"PackageDescription": "500 PELLET in 1 VIAL, GLASS (37662-0047-2) ",
"NDC11Code": "37662-0047-02",
"ProductNDC": "37662-0047",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Calcarea Acetica",
"NonProprietaryName": "Calcarea Acetica",
"DosageFormName": "PELLET",
"RouteName": "ORAL",
"StartMarketingDate": "20220517",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Hahnemann Laboratories, INC.",
"SubstanceName": "CALCIUM ACETATE",
"StrengthNumber": "1",
"StrengthUnit": "[hp_M]/1",
"Pharm_Classes": "Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]",
"Status": "Active",
"LastUpdate": "2022-05-19",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20220517",
"SamplePackage": "N"
},
{
"NDCCode": "40046-0047-1",
"PackageDescription": "1 TUBE in 1 CARTON (40046-0047-1) > 30 mL in 1 TUBE (40046-0047-2)",
"NDC11Code": "40046-0047-01",
"ProductNDC": "40046-0047",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Prep And Prime Face Protection",
"ProprietaryNameSuffix": "Spf 50",
"NonProprietaryName": "Zinc Oxide, Octinoxate",
"DosageFormName": "CREAM",
"RouteName": "TOPICAL",
"StartMarketingDate": "20060201",
"MarketingCategoryName": "OTC MONOGRAPH NOT FINAL",
"ApplicationNumber": "part352",
"LabelerName": "MAKEUP ART COSMETICS",
"SubstanceName": "ZINC OXIDE; OCTINOXATE",
"StrengthNumber": "16.1; 7.5",
"StrengthUnit": "mL/100mL; mL/100mL",
"Status": "Deprecated",
"LastUpdate": "2019-09-21",
"ProductNdcExcludeFlag": "E",
"ListingRecordCertifiedThrough": "20181231"
},
{
"NDCCode": "42413-0047-1",
"PackageDescription": "2 kg in 1 DRUM (42413-0047-1)",
"NDC11Code": "42413-0047-01",
"ProductNDC": "42413-0047",
"ProductTypeName": "BULK INGREDIENT",
"NonProprietaryName": "Dalfampridine",
"DosageFormName": "POWDER",
"StartMarketingDate": "20140609",
"MarketingCategoryName": "BULK INGREDIENT",
"LabelerName": "Enaltec Labs Pvt Ltd",
"SubstanceName": "DALFAMPRIDINE",
"StrengthNumber": "2",
"StrengthUnit": "kg/2kg",
"Status": "Deprecated",
"LastUpdate": "2014-02-04",
"ListingRecordCertifiedThrough": "20171231"
}
]
}
<?xml version="1.0" encoding="utf-8"?>
<NDCList>
<NDC>
<NDCCode>70163-0047-2</NDCCode>
<PackageDescription>1 BOTTLE, PLASTIC in 1 CARTON (70163-0047-2) / 120 TABLET in 1 BOTTLE, PLASTIC (70163-0047-1) </PackageDescription>
<NDC11Code>70163-0047-02</NDC11Code>
<ProductNDC>70163-0047</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Anxiety Relief</ProprietaryName>
<NonProprietaryName>Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Aurum Metallicum, Gelsemium Sempervirens, Hyoscyamus Niger, Ignatia Amara, Kali Carbonicum, Moschus, Natrum Muriaticum, Piper Methysticum</NonProprietaryName>
<DosageFormName>TABLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260415</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>ACONITUM NAPELLUS WHOLE; SILVER NITRATE; ARSENIC TRIOXIDE; GOLD; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; STRYCHNOS IGNATII SEED; POTASSIUM CARBONATE; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; SODIUM CHLORIDE; PIPER METHYSTICUM ROOT</SubstanceName>
<StrengthNumber>9; 8; 9; 8; 8; 6; 6; 12; 12; 6; 7</StrengthNumber>
<StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
<Pharm_Classes>Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-04-16</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260415</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve ■ occasional minor anxiety ■ fear ■ anguish ■ stress and worry of everyday life ■ nervousness*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0010-2</NDCCode>
<PackageDescription>1 BOTTLE, PLASTIC in 1 CARTON (70163-0010-2) / 125 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (70163-0010-1) </PackageDescription>
<NDC11Code>70163-0010-02</NDC11Code>
<ProductNDC>70163-0010</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>No More Monsters</ProprietaryName>
<NonProprietaryName>Calcarea Carbonica, Kali Phosphoricum, Lycopodium Clavatum, Passiflora Incarnata, Gallicum Acidum</NonProprietaryName>
<DosageFormName>TABLET, CHEWABLE</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260310</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>OYSTER SHELL CALCIUM CARBONATE, CRUDE; DIBASIC POTASSIUM PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; PASSIFLORA INCARNATA FLOWERING TOP; GALLIC ACID MONOHYDRATE</SubstanceName>
<StrengthNumber>6; 6; 6; 4; 6</StrengthNumber>
<StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
<Status>Active</Status>
<LastUpdate>2026-03-11</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260310</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve ■ frightful dreams ■ sleeplessness ■ frequent waking*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0012-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0012-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0012-1) </PackageDescription>
<NDC11Code>70163-0012-02</NDC11Code>
<ProductNDC>70163-0012</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Nervefix Sciatica</ProprietaryName>
<NonProprietaryName>Belladonna, Cimicifuga Racemosa, Gelsemium Sempervirens, Spigelia Anthelmia, Gnaphalium Polycephalum, Magnesia Phosphorica</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260203</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>ATROPA BELLADONNA; BLACK COHOSH; GELSEMIUM SEMPERVIRENS ROOT; SPIGELIA ANTHELMIA WHOLE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE</SubstanceName>
<StrengthNumber>6; 6; 6; 6; 6; 12</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-09-04</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260203</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve. ■ sciatica pain ■ pain extending into legs ■ neuralgia ■ back pain. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0013-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0013-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0013-1) </PackageDescription>
<NDC11Code>70163-0013-02</NDC11Code>
<ProductNDC>70163-0013</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Animal Hair And Dander</ProprietaryName>
<NonProprietaryName>Adrenalinum, Allium Cepa, Arsenicum Iodatum, Cat (dander), Dog (dander), Euphrasia Officinalis, Histaminum Hydrochloricum, Sabadilla, Sheep Wool, Silicea</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260410</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>EPINEPHRINE; ONION; ARSENIC TRIIODIDE; FELIS CATUS DANDER; CANIS LUPUS FAMILIARIS DANDER; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; SCHOENOCAULON OFFICINALE SEED; SHEEP WOOL; SILICON DIOXIDE</SubstanceName>
<StrengthNumber>6; 6; 6; 12; 12; 6; 12; 6; 12; 12</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-04-14</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260410</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve allergy symptoms. ■ congestion ■itchy, watery eyes ■ sneezing ■ rashes*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0017-2</NDCCode>
<PackageDescription>1 BOTTLE, PLASTIC in 1 CARTON (70163-0017-2) / 125 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (70163-0017-1) </PackageDescription>
<NDC11Code>70163-0017-02</NDC11Code>
<ProductNDC>70163-0017</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Peace And Quiet</ProprietaryName>
<NonProprietaryName>Chamomilla, Ignatia Amara, Lycopodium Clavatum, Magnesium Muriatica, Passiflora Incarnata</NonProprietaryName>
<DosageFormName>TABLET, CHEWABLE</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260302</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>MATRICARIA CHAMOMILLA WHOLE; STRYCHNOS IGNATII SEED; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; PASSIFLORA INCARNATA FLOWERING TOP</SubstanceName>
<StrengthNumber>4; 6; 6; 6; 4</StrengthNumber>
<StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
<Pharm_Classes>Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-03-04</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260302</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve ■ fussiness ■ oversensitivity ■ sleeplessness*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0018-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (70163-0018-2) / 30 mL in 1 BOTTLE, SPRAY (70163-0018-1) </PackageDescription>
<NDC11Code>70163-0018-02</NDC11Code>
<ProductNDC>70163-0018</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Thyroid Support</ProprietaryName>
<NonProprietaryName>Calcarea Carbonica, Calcarea Iodata, Causticum, Ferrum Iodatum, Fucus Vesiculosus, Kali Iodatum, Natrum Muriaticum, Thyroidinum (bovine)</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260304</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>OYSTER SHELL CALCIUM CARBONATE, CRUDE; CALCIUM IODIDE; CAUSTICUM; FERROUS IODIDE; FUCUS VESICULOSUS; POTASSIUM IODIDE; SODIUM CHLORIDE; THYROID, BOVINE</SubstanceName>
<StrengthNumber>10; 6; 10; 10; 6; 6; 10; 6</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-09-09</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260304</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help to provide temporary glandular support for symptoms of. ■ low energy ■ low metabolism ■ cold hands & feet ■ melancholy*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0019-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0019-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0019-1) </PackageDescription>
<NDC11Code>70163-0019-02</NDC11Code>
<ProductNDC>70163-0019</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Mold, Yeast And Dust</ProprietaryName>
<NonProprietaryName>Adrenalinum, Arsenicum Iodatum, Aspergillus Flavus, Aspergillus Fumigatus, Aspergillus Glaucus, Aspergillus Nidulans, Aspergillus Niger, Candida Albicans, Dermatophagoides Farinae, Histaminum Hydrochloricum, Lycopodium Clavatum, Mucor Plumbeus, Natrum Sulphuricum, Penicillium Digitatum, Penicillium Roquefortii, Saccharomyces Cerevisiae, Silicea</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260202</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>EPINEPHRINE; ARSENIC TRIIODIDE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; EUROTIUM HERBARIORUM; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; DERMATOPHAGOIDES FARINAE; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; MUCOR PLUMBEUS; SODIUM SULFATE; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI; SACCHAROMYCES CEREVISIAE; SILICON DIOXIDE</SubstanceName>
<StrengthNumber>6; 6; 12; 12; 12; 12; 12; 12; 12; 12; 6; 12; 6; 12; 12; 12; 12</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-02-10</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260202</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve allergy symptoms. ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0020-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (70163-0020-2) / 24 mL in 1 BOTTLE, SPRAY (70163-0020-1) </PackageDescription>
<NDC11Code>70163-0020-02</NDC11Code>
<ProductNDC>70163-0020</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Allergy Nasal</ProprietaryName>
<NonProprietaryName>Adrenalinum, Allium Cepa, Ambrosia Artemisiaefolia, Echinacea (angustifolia), Gelsemium Sempervirens, Kali Iodatum, Sanguinaria Canadensis, Sticta Pulmonaria</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260514</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>EPINEPHRINE; ONION; AMBROSIA ARTEMISIIFOLIA WHOLE; ECHINACEA ANGUSTIFOLIA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; POTASSIUM IODIDE; SANGUINARIA CANADENSIS ROOT; LOBARIA PULMONARIA</SubstanceName>
<StrengthNumber>6; 6; 12; 6; 6; 9; 6; 6</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-05-15</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260514</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve allergy symptoms. ■ sinus pressure ■ sinus headache ■ congestion ■ runny nose ■ dry nasal passages ■ sneezing *. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0023-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0023-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0023-1) </PackageDescription>
<NDC11Code>70163-0023-02</NDC11Code>
<ProductNDC>70163-0023</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Grass Pollen</ProprietaryName>
<NonProprietaryName>Adrenalinum, Allium Cepa, Arsenicum Iodatum, Oats (avena Sativa), Brome Grass (bromus Inermis), Bermuda Grass (cynodon Dactylon), Orchard Grass (dactylis Glomerata), Euphrasia Officinalis, Meadow Grass (festuca Elatior Pratensis), Histaminum Hydrochloricum, Perennial Rye Grass (lolium Perenne), Timothy Grass (phleum Pratense), Sabadilla, Sanguinaria Canadensis, Rye Grass (secale Cereale), Johnson Grass (sorghum Halepense), Wheat Grass (triticum Aestivum), Corn (zea Mays)</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260310</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>EPINEPHRINE; ONION; ARSENIC TRIIODIDE; AVENA SATIVA POLLEN; BROMUS INERMIS POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; EUPHRASIA STRICTA; LOLIUM PRATENSE POLLEN; HISTAMINE DIHYDROCHLORIDE; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; SCHOENOCAULON OFFICINALE SEED; SANGUINARIA CANADENSIS ROOT; SECALE CEREALE POLLEN; SORGHUM HALEPENSE POLLEN; TRITICUM AESTIVUM POLLEN; ZEA MAYS POLLEN</SubstanceName>
<StrengthNumber>6; 6; 6; 12; 12; 12; 12; 6; 12; 12; 12; 12; 6; 6; 12; 12; 12; 12</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-03-11</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260310</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve allergy symptoms. ■ runny nose ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0024-2</NDCCode>
<PackageDescription>1 BOTTLE, GLASS in 1 CARTON (70163-0024-2) / 120 mL in 1 BOTTLE, GLASS (70163-0024-1) </PackageDescription>
<NDC11Code>70163-0024-02</NDC11Code>
<ProductNDC>70163-0024</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Cough And Mucus Night</ProprietaryName>
<NonProprietaryName>Antimonium Tartaricum, Avena Sativa, Bryonia (alba), Chamomilla, Drosera (rotundifolia), Hepar Sulphuris Calcareum, Hydrastis Canadensis, Kali Bichromicum, Passiflora Incarnata, Pulsatilla (pratensis), Sambucus Nigra, Stannum Metallicum, Sulphur</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260202</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>ANTIMONY POTASSIUM TARTRATE; AVENA SATIVA FLOWERING TOP; BRYONIA ALBA ROOT; MATRICARIA CHAMOMILLA WHOLE; DROSERA ROTUNDIFOLIA WHOLE; CALCIUM SULFIDE; GOLDENSEAL; POTASSIUM DICHROMATE; PASSIFLORA INCARNATA FLOWERING TOP; PULSATILLA PRATENSIS WHOLE; SAMBUCUS NIGRA FLOWERING TOP; TIN; SULFUR</SubstanceName>
<StrengthNumber>6; 8; 6; 8; 6; 12; 5; 12; 6; 6; 3; 12; 12</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Active</Status>
<LastUpdate>2026-02-04</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260202</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve ■ chest congestion ■ hacking cough ■ thick mucus in chest, throat and nose*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0025-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0025-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0025-1) </PackageDescription>
<NDC11Code>70163-0025-02</NDC11Code>
<ProductNDC>70163-0025</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Candida Yeast Care</ProprietaryName>
<NonProprietaryName>Baptisia Tinctoria, Bryonia (alba), Candida Albicans, Candida Parapsilosis, Echinacea (angustifolia), Eupatorium Perfoliatum, Thuja Occidentalis, Viscum Album</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260501</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>BAPTISIA TINCTORIA WHOLE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP</SubstanceName>
<StrengthNumber>3; 3; 12; 12; 3; 6; 3; 3</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-05-05</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260501</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve. ■ symptoms of yeast infection ■ itching ■ burning ■ discharge ■ odor*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0029-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0029-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0029-1) </PackageDescription>
<NDC11Code>70163-0029-02</NDC11Code>
<ProductNDC>70163-0029</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Tree Pollen</ProprietaryName>
<NonProprietaryName>Acer Negundo, Acer Rubrum, Adrenalinum, Allium Cepa, Arsenicum Iodatum, Betula Nigra, Euphrasia Officinalis, Fraxinus Americana, Histaminum Hydrochloricum, Ligustrum Vulgare, Liquidambar Styraciflua, Morus Alba, Pinus Strobus, Populus Deltoides, Quercus Rubra, Sabadilla, Salix Nigra, Sanguinaria Canadensis</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260304</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; EPINEPHRINE; ONION; ARSENIC TRIIODIDE; BETULA NIGRA POLLEN; EUPHRASIA STRICTA; FRAXINUS AMERICANA POLLEN; HISTAMINE DIHYDROCHLORIDE; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; MORUS ALBA POLLEN; PINUS STROBUS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SCHOENOCAULON OFFICINALE SEED; SALIX NIGRA POLLEN; SANGUINARIA CANADENSIS ROOT</SubstanceName>
<StrengthNumber>12; 12; 6; 6; 6; 12; 6; 12; 12; 12; 12; 12; 12; 12; 12; 6; 12; 6</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-09-04</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260304</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve allergy symptoms. ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0030-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0030-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0030-1) </PackageDescription>
<NDC11Code>70163-0030-02</NDC11Code>
<ProductNDC>70163-0030</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Sinufix</ProprietaryName>
<NonProprietaryName>Thuja Occidentalis, Antimonium Tartaricum, Kali Bichromicum, Mercurius Iodatus Ruber, Spongia Tosta, Hepar Sulphuris Calcareum</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260422</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>THUJA OCCIDENTALIS LEAFY TWIG; ANTIMONY POTASSIUM TARTRATE; POTASSIUM DICHROMATE; MERCURIC IODIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; CALCIUM SULFIDE</SubstanceName>
<StrengthNumber>6; 6; 6; 12; 10; 10</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Active</Status>
<LastUpdate>2026-04-25</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260422</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve. ■ sinus symptoms ■ sinus headache ■ nasal congestion ■ sinus pressure ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0031-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0031-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0031-1) </PackageDescription>
<NDC11Code>70163-0031-02</NDC11Code>
<ProductNDC>70163-0031</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Pollen Hayfever</ProprietaryName>
<NonProprietaryName>Adrenalinum, Allium Cepa, Ambrosia Artemisiaefolia, Arsenicum Iodatum, Mugwort Pollen (artemisia Vulgaris), Bellis Perennis, Brassica Spp, Chenopodium Album, Euphrasia Officinalis, Histaminum Hydrochloricum, Alfalfa Pollen (medicago Sativa), Phleum Pratense, Yellow Dock Pollen (rumex Crispus), Sabadilla, Silicea, Goldenrod Pollen (solidago Canadensis), Dandelion Pollen (taraxacum Officinale), Red Clover Pollen (trifolium Pratense), Xanthium Strumarium</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260505</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>EPINEPHRINE; ONION; AMBROSIA ARTEMISIIFOLIA WHOLE; ARSENIC TRIIODIDE; ARTEMISIA VULGARIS POLLEN; BELLIS PERENNIS WHOLE; BRASSICA RAPA SUBSP. OLEIFERA POLLEN; CHENOPODIUM ALBUM POLLEN; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; MEDICAGO SATIVA POLLEN; PHLEUM PRATENSE POLLEN; RUMEX CRISPUS POLLEN; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SOLIDAGO CANADENSIS POLLEN; TARAXACUM OFFICINALE POLLEN; TRIFOLIUM PRATENSE POLLEN; XANTHIUM STRUMARIUM POLLEN</SubstanceName>
<StrengthNumber>6; 6; 12; 6; 12; 12; 12; 12; 6; 12; 12; 12; 12; 6; 12; 12; 12; 12; 12</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-05-07</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260505</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve allergy symptoms. ■ runny nose ■ congestion ■ headache ■ itchy, watery eyes, ■ sneezing*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0033-2</NDCCode>
<PackageDescription>1 BOTTLE, PLASTIC in 1 CARTON (70163-0033-2) / 125 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (70163-0033-1) </PackageDescription>
<NDC11Code>70163-0033-02</NDC11Code>
<ProductNDC>70163-0033</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>A Plus Attention</ProprietaryName>
<NonProprietaryName>Baryta Carbonica, Calcarea Phosphorica, Silicea, Gelsemium Sempervirens, Nux Vomica, Sinapis Nigra</NonProprietaryName>
<DosageFormName>TABLET, CHEWABLE</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260324</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>BARIUM CARBONATE; TRIBASIC CALCIUM PHOSPHATE; SILICON DIOXIDE; GELSEMIUM SEMPERVIRENS ROOT; STRYCHNOS NUX-VOMICA SEED; BLACK MUSTARD SEED</SubstanceName>
<StrengthNumber>10; 10; 10; 12; 12; 12</StrengthNumber>
<StrengthUnit>[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1</StrengthUnit>
<Pharm_Classes>Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-03-27</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260324</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve ■ poor concentration ■ overactive mind ■ restlessness*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0034-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0034-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0034-1) </PackageDescription>
<NDC11Code>70163-0034-02</NDC11Code>
<ProductNDC>70163-0034</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Adrenal Support</ProprietaryName>
<NonProprietaryName>Adrenalinum, Argentum Nitricum, Berberis Vulgaris, Natrum Muriaticum, Oleum Morrhuae, Petroleum, Vanadium</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260324</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>EPINEPHRINE; SILVER NITRATE; BERBERIS VULGARIS ROOT BARK; SODIUM CHLORIDE; COD LIVER OIL; KEROSENE; VANADIUM</SubstanceName>
<StrengthNumber>6; 10; 6; 10; 12; 12; 10</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-09-04</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260324</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help to provide temporary glandular support for symptoms of. ■ low energy ■ low metabolism ■ inflammation ■ stress. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0035-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0035-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0035-1) </PackageDescription>
<NDC11Code>70163-0035-02</NDC11Code>
<ProductNDC>70163-0035</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Allergy Care</ProprietaryName>
<NonProprietaryName>Adrenalinum, Ragweed, Pollen (ambrosia Artemisiaefolia), Apis Mellifica, Echinacea (angustifolia), Histaminum Hydrochloricum, Ledum Palustre, Lycopodium Clavatum, Natrum Muriaticum, Sulphur</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260323</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>EPINEPHRINE; AMBROSIA ARTEMISIIFOLIA POLLEN; APIS MELLIFERA; ECHINACEA ANGUSTIFOLIA WHOLE; HISTAMINE DIHYDROCHLORIDE; RHODODENDRON TOMENTOSUM LEAFY TWIG; LYCOPODIUM CLAVATUM SPORE; SODIUM CHLORIDE; SULFUR</SubstanceName>
<StrengthNumber>6; 6; 6; 4; 12; 8; 6; 8; 6</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Standardized Insect Venom Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-08-28</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260323</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve allergy symptoms of ■ nasal and sinus congestion ■ runny nose ■ skin irritations ■ sneezing ■ watery eyes*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0036-2</NDCCode>
<PackageDescription>1 BOTTLE, GLASS in 1 CARTON (70163-0036-2) / 120 mL in 1 BOTTLE, GLASS (70163-0036-1) </PackageDescription>
<NDC11Code>70163-0036-02</NDC11Code>
<ProductNDC>70163-0036</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Cough And Mucus</ProprietaryName>
<NonProprietaryName>Antimonium Tartaricum, Euphrasia Officinalis, Hepar Sulphuris Calcareum, Hydrastis Canadensis, Kali Bichromicum, Pulsatilla (pratensis), Stannum Metallicum, Sulphur</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260323</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>ANTIMONY POTASSIUM TARTRATE; EUPHRASIA STRICTA; CALCIUM SULFIDE; GOLDENSEAL; POTASSIUM DICHROMATE; PULSATILLA PRATENSIS WHOLE; TIN; SULFUR</SubstanceName>
<StrengthNumber>6; 6; 12; 5; 12; 6; 12; 12</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Active</Status>
<LastUpdate>2026-03-27</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260323</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve ■ chest congestion ■ hacking cough ■ thick mucus in chest, throat and nose*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0039-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0039-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0039-1) </PackageDescription>
<NDC11Code>70163-0039-02</NDC11Code>
<ProductNDC>70163-0039</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Uti Care</ProprietaryName>
<NonProprietaryName>Barosma (betulina), Dulcamara, Equisetum Hyemale, Terebinthina, Sarsaparilla (smilax Regelii) Triticum Repens</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260320</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>AGATHOSMA BETULINA LEAF; SOLANUM DULCAMARA TOP; EQUISETUM HYEMALE WHOLE; TURPENTINE OIL; SMILAX ORNATA ROOT; ELYMUS REPENS ROOT</SubstanceName>
<StrengthNumber>5; 3; 6; 4; 4; 4</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Active</Status>
<LastUpdate>2026-03-23</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260320</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve. ■ bladder symptoms ■ urge to urinate ■ frequent urination ■ painful urination. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>70163-0040-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (70163-0040-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0040-1) </PackageDescription>
<NDC11Code>70163-0040-02</NDC11Code>
<ProductNDC>70163-0040</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Cold And Flu Relief</ProprietaryName>
<NonProprietaryName>Aconitum Napellus, Allium Cepa, Echinacea (angustifolia), Euphrasia Officinalis, Gelsemium Sempervirens, Sanguinaria Canadensis, Sticta Pulmonaria</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20260323</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>NaturalCare</LabelerName>
<SubstanceName>ACONITUM NAPELLUS WHOLE; ONION; ECHINACEA ANGUSTIFOLIA WHOLE; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; SANGUINARIA CANADENSIS ROOT; LOBARIA PULMONARIA</SubstanceName>
<StrengthNumber>3; 6; 3; 6; 6; 6; 6</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-08-28</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20260323</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May help temporarily relieve. ■ congestion ■ cough ■ nausea ■ sneezing ■ runny nose ■ headache ■ body ache*. *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>0009-0047-04</NDCCode>
<PackageDescription>25 VIAL in 1 CARTON (0009-0047-04) / 2 mL in 1 VIAL (0009-0047-03) </PackageDescription>
<NDC11Code>00009-0047-04</NDC11Code>
<ProductNDC>0009-0047</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Solu-medrol</ProprietaryName>
<NonProprietaryName>Methylprednisolone Sodium Succinate</NonProprietaryName>
<DosageFormName>INJECTION, POWDER, FOR SOLUTION</DosageFormName>
<RouteName>INTRAMUSCULAR; INTRAVENOUS</RouteName>
<StartMarketingDate>19590402</StartMarketingDate>
<MarketingCategoryName>NDA</MarketingCategoryName>
<ApplicationNumber>NDA011856</ApplicationNumber>
<LabelerName>Pharmacia & Upjohn Company LLC</LabelerName>
<SubstanceName>METHYLPREDNISOLONE SODIUM SUCCINATE</SubstanceName>
<StrengthNumber>125</StrengthNumber>
<StrengthUnit>mg/2mL</StrengthUnit>
<Pharm_Classes>Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-06-27</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>19590402</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-MEDROL Sterile Powder is indicated as follows. Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis. Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia. Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.</IndicationAndUsage>
<Description>SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. The chemical name for methylprednisolone sodium succinate is pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-monosodium salt, (6α, 11β), and the molecular weight is 496.53. The structural formula is represented below. Methylprednisolone sodium succinate is soluble in water; it may be administered in a small volume of diluent and is well suited for intravenous use in situations where high blood levels of methylprednisolone are required rapidly. SOLU-MEDROL is available in preservative and preservative-free formulations. When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8.</Description>
</NDC>
<NDC>
<NDCCode>0009-0047-22</NDCCode>
<PackageDescription>25 VIAL in 1 CARTON (0009-0047-22) / 2 mL in 1 VIAL (0009-0047-25) </PackageDescription>
<NDC11Code>00009-0047-22</NDC11Code>
<ProductNDC>0009-0047</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Solu-medrol</ProprietaryName>
<NonProprietaryName>Methylprednisolone Sodium Succinate</NonProprietaryName>
<DosageFormName>INJECTION, POWDER, FOR SOLUTION</DosageFormName>
<RouteName>INTRAMUSCULAR; INTRAVENOUS</RouteName>
<StartMarketingDate>19590402</StartMarketingDate>
<MarketingCategoryName>NDA</MarketingCategoryName>
<ApplicationNumber>NDA011856</ApplicationNumber>
<LabelerName>Pharmacia & Upjohn Company LLC</LabelerName>
<SubstanceName>METHYLPREDNISOLONE SODIUM SUCCINATE</SubstanceName>
<StrengthNumber>125</StrengthNumber>
<StrengthUnit>mg/2mL</StrengthUnit>
<Pharm_Classes>Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2025-12-17</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>19590402</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-MEDROL Sterile Powder is indicated as follows. Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis. Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia. Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.</IndicationAndUsage>
<Description>SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. The chemical name for methylprednisolone sodium succinate is pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-monosodium salt, (6α, 11β), and the molecular weight is 496.53. The structural formula is represented below. Methylprednisolone sodium succinate is soluble in water; it may be administered in a small volume of diluent and is well suited for intravenous use in situations where high blood levels of methylprednisolone are required rapidly. SOLU-MEDROL is available in preservative and preservative-free formulations. When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8.</Description>
</NDC>
<NDC>
<NDCCode>0009-0047-26</NDCCode>
<PackageDescription>25 VIAL in 1 CARTON (0009-0047-26) / 2 mL in 1 VIAL (0009-0047-27) </PackageDescription>
<NDC11Code>00009-0047-26</NDC11Code>
<ProductNDC>0009-0047</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Solu-medrol</ProprietaryName>
<NonProprietaryName>Methylprednisolone Sodium Succinate</NonProprietaryName>
<DosageFormName>INJECTION, POWDER, FOR SOLUTION</DosageFormName>
<RouteName>INTRAMUSCULAR; INTRAVENOUS</RouteName>
<StartMarketingDate>19590402</StartMarketingDate>
<MarketingCategoryName>NDA</MarketingCategoryName>
<ApplicationNumber>NDA011856</ApplicationNumber>
<LabelerName>Pharmacia & Upjohn Company LLC</LabelerName>
<SubstanceName>METHYLPREDNISOLONE SODIUM SUCCINATE</SubstanceName>
<StrengthNumber>125</StrengthNumber>
<StrengthUnit>mg/2mL</StrengthUnit>
<Pharm_Classes>Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2025-12-17</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>19590402</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-MEDROL Sterile Powder is indicated as follows. Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis. Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia. Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.</IndicationAndUsage>
<Description>SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. The chemical name for methylprednisolone sodium succinate is pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-monosodium salt, (6α, 11β), and the molecular weight is 496.53. The structural formula is represented below. Methylprednisolone sodium succinate is soluble in water; it may be administered in a small volume of diluent and is well suited for intravenous use in situations where high blood levels of methylprednisolone are required rapidly. SOLU-MEDROL is available in preservative and preservative-free formulations. When necessary, the pH of each formula was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7 to 8.</Description>
</NDC>
<NDC>
<NDCCode>0280-0047-36</NDCCode>
<PackageDescription>18 POUCH in 1 CARTON (0280-0047-36) / 2 TABLET, EFFERVESCENT in 1 POUCH</PackageDescription>
<NDC11Code>00280-0047-36</NDC11Code>
<ProductNDC>0280-0047</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Alka-seltzer Heartburn</ProprietaryName>
<NonProprietaryName>Anhydrous Citric Acid, Sodium Bicarbonate (heat-treated)</NonProprietaryName>
<DosageFormName>TABLET, EFFERVESCENT</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100302</StartMarketingDate>
<MarketingCategoryName>OTC MONOGRAPH DRUG</MarketingCategoryName>
<ApplicationNumber>M001</ApplicationNumber>
<LabelerName>Bayer HealthCare LLC.</LabelerName>
<SubstanceName>CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE</SubstanceName>
<StrengthNumber>1000; 1940</StrengthNumber>
<StrengthUnit>mg/1; mg/1</StrengthUnit>
<Pharm_Classes>Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2025-12-06</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20100302</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>for the relief of: 1 heartburn, 2 acid indigestion, 3 upset stomach associated with these symptoms .</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>0338-0047-29</NDCCode>
<PackageDescription>2 BAG in 1 CARTON (0338-0047-29) / 5000 mL in 1 BAG</PackageDescription>
<NDC11Code>00338-0047-29</NDC11Code>
<ProductNDC>0338-0047</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Sodium Chloride</ProprietaryName>
<NonProprietaryName>Sodium Chloride</NonProprietaryName>
<DosageFormName>IRRIGANT</DosageFormName>
<RouteName>IRRIGATION</RouteName>
<StartMarketingDate>19800530</StartMarketingDate>
<MarketingCategoryName>NDA</MarketingCategoryName>
<ApplicationNumber>NDA017867</ApplicationNumber>
<LabelerName>Baxter Healthcare Corporation</LabelerName>
<SubstanceName>SODIUM CHLORIDE</SubstanceName>
<StrengthNumber>900</StrengthNumber>
<StrengthUnit>mg/100mL</StrengthUnit>
<Pharm_Classes>Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2026-03-19</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20271231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>19800530</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>0.9% Sodium Chloride Irrigation, USP is indicated for use as an arthroscopic irrigating fluid with endoscopic instruments during arthroscopic procedures requiring distension and irrigation of the knee, shoulder, elbow, or other bone joints.</IndicationAndUsage>
<Description>0.9% Sodium Chloride Irrigation, USP is a sterile nonpyrogenic, isotonic solution in a single dose ARTHROMATIC plastic container for use as an arthroscopic irrigating solution. Each liter contains 9 g Sodium Chloride, USP (NaCl) in Water for Injection. pH 5.5 (4.5 to 7.0). Milliequivalents per liter: Sodium - 154, Chloride - 154. Osmolarity 308 mOsmol/L (calc.). No antimicrobial agent has been added. The ARTHROMATIC plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexylphthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.</Description>
</NDC>
<NDC>
<NDCCode>11822-0047-2</NDCCode>
<PackageDescription>24 BLISTER PACK in 1 CARTON (11822-0047-2) > 1 TABLET in 1 BLISTER PACK</PackageDescription>
<NDC11Code>11822-0047-02</NDC11Code>
<ProductNDC>11822-0047</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Acid Reducer</ProprietaryName>
<NonProprietaryName>Ranitidine</NonProprietaryName>
<DosageFormName>TABLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20081203</StartMarketingDate>
<MarketingCategoryName>ANDA</MarketingCategoryName>
<ApplicationNumber>ANDA078653</ApplicationNumber>
<LabelerName>Rite Aid Corporation</LabelerName>
<SubstanceName>RANITIDINE HYDROCHLORIDE</SubstanceName>
<StrengthNumber>150</StrengthNumber>
<StrengthUnit>mg/1</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2017-11-15</LastUpdate>
</NDC>
<NDC>
<NDCCode>15631-0047-2</NDCCode>
<PackageDescription>400 PELLET in 1 PACKAGE (15631-0047-2) </PackageDescription>
<NDC11Code>15631-0047-02</NDC11Code>
<ProductNDC>15631-0047</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Argentum Phosphoricum</ProprietaryName>
<NonProprietaryName>Argentum Phosphoricum</NonProprietaryName>
<DosageFormName>PELLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20150907</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Rxhomeo Private Limited d.b.a. Rxhomeo, Inc</LabelerName>
<SubstanceName>SILVER PHOSPHATE</SubstanceName>
<StrengthNumber>3</StrengthNumber>
<StrengthUnit>[hp_X]/1</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2022-01-04</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20211231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20180101</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>Condition listed above or as directed by the physician.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>37662-0047-2</NDCCode>
<PackageDescription>500 PELLET in 1 VIAL, GLASS (37662-0047-2) </PackageDescription>
<NDC11Code>37662-0047-02</NDC11Code>
<ProductNDC>37662-0047</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Calcarea Acetica</ProprietaryName>
<NonProprietaryName>Calcarea Acetica</NonProprietaryName>
<DosageFormName>PELLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20220517</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Hahnemann Laboratories, INC.</LabelerName>
<SubstanceName>CALCIUM ACETATE</SubstanceName>
<StrengthNumber>1</StrengthNumber>
<StrengthUnit>[hp_M]/1</StrengthUnit>
<Pharm_Classes>Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2022-05-19</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20220517</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
</NDC>
<NDC>
<NDCCode>40046-0047-1</NDCCode>
<PackageDescription>1 TUBE in 1 CARTON (40046-0047-1) > 30 mL in 1 TUBE (40046-0047-2)</PackageDescription>
<NDC11Code>40046-0047-01</NDC11Code>
<ProductNDC>40046-0047</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Prep And Prime Face Protection</ProprietaryName>
<ProprietaryNameSuffix>Spf 50</ProprietaryNameSuffix>
<NonProprietaryName>Zinc Oxide, Octinoxate</NonProprietaryName>
<DosageFormName>CREAM</DosageFormName>
<RouteName>TOPICAL</RouteName>
<StartMarketingDate>20060201</StartMarketingDate>
<MarketingCategoryName>OTC MONOGRAPH NOT FINAL</MarketingCategoryName>
<ApplicationNumber>part352</ApplicationNumber>
<LabelerName>MAKEUP ART COSMETICS</LabelerName>
<SubstanceName>ZINC OXIDE; OCTINOXATE</SubstanceName>
<StrengthNumber>16.1; 7.5</StrengthNumber>
<StrengthUnit>mL/100mL; mL/100mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2019-09-21</LastUpdate>
<ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20181231</ListingRecordCertifiedThrough>
</NDC>
<NDC>
<NDCCode>42413-0047-1</NDCCode>
<PackageDescription>2 kg in 1 DRUM (42413-0047-1)</PackageDescription>
<NDC11Code>42413-0047-01</NDC11Code>
<ProductNDC>42413-0047</ProductNDC>
<ProductTypeName>BULK INGREDIENT</ProductTypeName>
<NonProprietaryName>Dalfampridine</NonProprietaryName>
<DosageFormName>POWDER</DosageFormName>
<StartMarketingDate>20140609</StartMarketingDate>
<MarketingCategoryName>BULK INGREDIENT</MarketingCategoryName>
<LabelerName>Enaltec Labs Pvt Ltd</LabelerName>
<SubstanceName>DALFAMPRIDINE</SubstanceName>
<StrengthNumber>2</StrengthNumber>
<StrengthUnit>kg/2kg</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2014-02-04</LastUpdate>
<ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
</NDC>
</NDCList>